{"database": "lobbying", "table": "lobbying_activities", "rows": [[1837918, "6d2a4619-0d9a-4711-9b07-e81478c684ae", "Q2", "MR. BRIAN KELLY", 40024191, "INTELLIA THERAPEUTICS", 2016, "second_quarter", "MED", "Gene Editing", "HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Natl Science Foundation (NSF),SENATE,White House Office", 15000, null, 0, 0, "2016-07-06T18:05:34.250000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1837918"], "units": {}, "query_ms": 0.33455388620495796, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}